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▼The site-specific recombinases Cre and Flp are being used
increasingly as tools for genomic engineering of eukaryotic
cell lines (Ref. 1). The utility of site-specific recombination
(SR) has led to the design of elaborate experiments that em-
ploy more than one recombinase (Ref. 2), for example: the
targeted introduction of a transgene and the subsequent
deletion of the selection marker; and the sequential exci-
sion of two bordering elements from a chromatin domain
(Ref. 3 and see below). In theory the versatility of these
SR-based systems is tremendous, while, in practice, many
experiments are limited by the efficiency of the recombina-
tion reaction, which conventionally requires drug-selection
schemes to enrich for cells with the desired event.
Recently, it has been demonstrated that the Flp enzyme
is more thermolabile than Cre (Ref. 2), which might re-
strict its use to systems that are vital at <35◦C and probably
explains the preferential use of Cre for the creation of trans-
genic mice (Ref. 4). While the thermodynamically favored
excision step will profit from an extended and high activity
of the recombinase (Ref. 5), this is not necessarily true for
the reverse integration reaction. In this case, a compromise
must be found between a sufficiently high initial level and
a short duration of recombinase activity. If activity persists,
re-excision would be an inevitable consequence (Figure 1
and Ref. 6).
We have developed a bicistronic construct (pFIG; Figure
1) coexpressing Flp andGfp, to enable FACS sorting of those
cells that can be expected to express Flp. With this con-
struct, we can address the question whether recombination
efficiency, transfection rate, or both are limiting steps in
recovering SR events. If it is the transfection rate only, we
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have available a procedure in which recombination events
can be enriched without a drug-resistance marker.
The present study was performed during pilot engineer-
ing experiments on a biotechnologically relevant cell line,
Baby Hampster Kidney (BHK), and it is based on the blue
and white screening protocol introduced by O’Gorman
et al. (Ref. 7). This procedure monitors excision, indicated
by the restoration of the region encoding lacZ (white to
blue transition, see Figure 1) and targeted insertion, indi-
cated by the interruption of a lacZ reading frame (blue to
white transition). While blue color would arise from a sin-
gle excision event, even in the context of multiple inserted
copies, integration would probably escape detection if more
than a single copy were present. To overcome the associ-
ated problems, we have transferred the construct by retrovi-
ral infection, which guarantees the integration of authentic
single copies at open genomic loci with high transcriptional
potential (Ref. 8).
pFIG was transfected into a clonal cell line of this origin
and the efficiency for excising the neor reading frame with
and without FACS sorting was compared. Figure 2 gives
details of the sorting procedure, which starts with a defi-
nition of intact cells (left), and which is performed under
conditions that recover high expressors. Among these, the
percentage of blue cells was calculated and found to be
5% without and 95% after FACS enrichment, respectively
(Figure 3). The lower level closely resembles the transfection
efficiency of BHK cells under these conditions, indicating
that a high proportion of successfully transfected cells has
lost the neor insert. This is confirmed by the 95% share of
blue cells that is attained after sorting for Gfp expression.
Therefore, it is concluded that virtually every cell receiving
pFIG expresses Flp recombinase at a level that is sufficient
for excision. Based on this finding, it is possible to isolate
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FIGURE 1. pMFNZ: the primary target was constructed from the 3.5 kb SalI/PstI fragment of pM5SePa (Ref. 8) and a 4.6 kb PCR fragment derived from
pNeobgal (Ref. 7) using the 59NsiI (compatible with PstI) and 3′SalI sites, respectively. pFIG was composed using the pSBC system (Ref. 17): SmaI/SalI-cut
pSBC1 was provided with the 1650 bp Flp-coding fragment from pOG44 (Ref. 7), under the control of the SV40 promoter. EcoRI/HindIII-cut pSBC2
received the 750 bp EcoRI-HindIII gfp fragment from pGFP10 (Ref. 18). XmnI/NotI fragments from both vectors were combined. Recombination
experiments with pFIG were performed in parallel with and without FACS sorting for Gfp. Integration vector pOG45 (Ref. 7) is regenerated by the
excision reaction.
cells with the desired excision event directly, without the
need for tedious drug-resistance screening procedures.
There is only one reported example where the transient
expression of a classical drug-resistance marker (pac) suf-
ficed for the selection of transfected embryonic stem (ES)
cells (Ref. 9). This procedure is probably restricted to that
cell type, which is killed within two days by puromycin
but not by a different selection drug (Ref. 9). Other systems
require the stable expression, that is, integration, of the se-
lection marker and further Southern analysis to eliminate
spontaneously resistant cells (Ref. 10). Even in this case, re-
covered clones are not strictly comparable because each of
them will have accommodated the transgene(s) at a differ-
ent genomic site. There is also the danger of long-term ge-
nomic rearrangements caused by a continuously expressed
recombinase (Ref. 11).
In order to evaluate the integration reaction according
to (Ref. 7), cells transfected by pOG45 must be pre-selected
in a medium containing G418. Resistant cells that have ac-
quired pOG45, either by site-specific integration (white) or
by nonspecific integration of the same plasmid (blue), are
then enumerated. The percentage of white cells is plotted in
Figure 3 for parallel experiments in the presence or absence
of the sorting step, demonstrating a twofold advantage for
the FACS-based system under these specific conditions. It
should be noted that FACS sorting permits the careful op-
timization of Flp levels, which must provide an initial ac-
tivity that is high enough to enable integration, but which
must decay during this process to a level that discourages
re-excision.
It did not escape our attention that the proportion of blue
cells (8%) (Ref. 4) in these experiments is far below the 50%
mark reported for a tester strain (E25B2) of the CV1 cell line
(Ref. 7), which has been reproduced in a number of labora-
tories, including our own (Ref. 12). This favorable result is
probably due to a lower rate of illegitimate recombination
for that cell line, in conjunction with a particularly acces-
sible target in this particular clone. It cannot be ascribed to
a differential expression of Flp activities, which are, on the
contrary, comparable in CV1 and BHK cells (Ref. 5).
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FIGURE 2. FACS-sorting of pFIG-transfected BHK-A cells. The encircled population was defined according to size (FSC) and granularity (SSC) to
exclude aggregates and debris from the analysis. A window was then chosen for isolating cells with a high and specific expression of Gfp (and thereby Flp).
Conclusions and perspective
Here, we describe conditions that permit quantitative Flp-
mediated excision in cells cultured at 37◦C, without the
need of a drug-resistance marker, which would involve
time-consuming selection procedures and secondary prob-
lems if Flp and marker genes were integrated and perma-
nently expressed. Based on a vector (RSV-GFPcre) encoding
a fusion protein with a GFP domain at its N-terminal end, a
related approach has recently been suggested for Cre recom-
binase (Ref. 13). These studies together provide a complete
set of tools for the stepwise decomposition of a complete
chromatin minidomain in the living cell. Our model con-
structs consist of a reporter gene flanked by two bordering
elements (scaffold/matrix-attached regions, S/MARs). These
borders are excised by either Flp (upstream) or Cre recom-
binase (downstream; Ref. 3), revealing dramatic differences
for the effect of S/MARs depending on the nature of the
integration site. It should be noted that this type of in-
formation cannot be obtained with standard transfection
techniques, which compare the efficiency of two separate
constructs (reporter gene with or without bordering ele-
ments) in parallel experiments that by no means guarantee
that similar classes of integration sites are hit in both cases
(Ref. 3). We have also proposed an approach by which the
efficiency of Flp-mediated integration reactions can be im-
proved by selecting for cells with an optimum level of re-
combinase expression. This protocol is now used routinely
for a ‘clean’ modification of cells by site-specific recombina-
tion, avoiding the use of a selection marker and its adverse
consequences during the recovery of Flp-expressing cells
(Ref. 14).
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FIGURE 3. Percentage of blue cells in parallel excision reactions mediated by pFIG with or without sorting for Gfp/Flp (left-hand graph). Percentage of
G418-resistant (white) cells after transfection of pFIG plus pOG45 with or without sorting (right-hand graph).
Protocol
Cell culture
Baby Hamster Kidney cells (strain BHK A) are cultured in
Dulbecco’s modified Eagle medium (DME) (Sigma, cata-
logue no. D-5648) containing 10% fetal calf serum (FCS)
(Boehringer Ingelheim Bioproducts, catalogue no. 14-501F)
and transfected as described in (Ref. 15).
Retroviral gene transfer
Infectious retroviral particles are generated after transfect-
ing pMFNZ under stable expression conditions into ψ2
packaging cells (Ref. 15). The supernatants of these cells
is used for an infection of BHK at a multiplicity of infection
that renders 1 per 1000 resistant cells.
Flp-mediated reactions
Non-confluent BHK cells from a 55 cm2 dish are transfected
with 10 µg circular pFIG (excision) or 10 µg pFIG plus 5 µg
pOG45 (integration). After 48 h, the ratio of blue:white cells
obtained with or without FACS sorting is determined.
FACS sorting
Cells are washed with PBS at 37◦C, trypsinized and trans-
ferred to FACS buffer: PBS containing 2% FCS (Boehringer
Ingelheim Bioproducts, catalogue no. 14-501F) after pas-
sage through a 0.22 µm filter. After centrifugation (5 min,
200 g at 4◦C), they are resuspended in FACS buffer at a con-
centration of 106 ml−1 and passed through a 35 µm pore
nylon mesh [Polyestergewebe 61 QST 126.153) Seidengaze-
fabrik AG.]. Aggregates and cell debris are either excluded,
as demonstrated in Figure 2, or by means of the red or
blue fluorescence they develop in the presence of 5 µg ml−1
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propidium iodide (Ref. 16). FACS analyses are performed at
an excitation wavelength of 488 nm (argon-ion laser). 509
nm emission is monitored with a 530/30 nm band path
filter.
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